Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1615-02-7

Post Buying Request

1615-02-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1615-02-7 Usage

Chemical Properties

white to light yellow crystal powder

Uses

4-Chlorocinnamic Acid is a derivative of Cinnamic Acid (C442030) and plays an important role in the development of plants. 4-Chlorocinnamic Acid may also show potential antimicrobial, antioxidant, anti-inflammatory, and antitumoral activity.

Purification Methods

Recrystallise the acid from EtOH or aqueous EtOH (charcoal). UV has max at 275nm (EtOH). [Walling & Wolfstirn J Am Chem Soc 69 852 1947, Beilstein 9 H 596, 9 II 395, 9 III 2727, 9 IV 2033.]

Check Digit Verification of cas no

The CAS Registry Mumber 1615-02-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,1 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1615-02:
(6*1)+(5*6)+(4*1)+(3*5)+(2*0)+(1*2)=57
57 % 10 = 7
So 1615-02-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H7ClO2/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6H,(H,11,12)/p-1/b6-3+

1615-02-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A15304)  4-Chlorocinnamic acid, predominantly trans, 99%   

  • 1615-02-7

  • 25g

  • 528.0CNY

  • Detail
  • Alfa Aesar

  • (A15304)  4-Chlorocinnamic acid, predominantly trans, 99%   

  • 1615-02-7

  • 100g

  • 1496.0CNY

  • Detail
  • Alfa Aesar

  • (A15304)  4-Chlorocinnamic acid, predominantly trans, 99%   

  • 1615-02-7

  • 500g

  • 6411.0CNY

  • Detail

1615-02-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chlorocinnamic acid

1.2 Other means of identification

Product number -
Other names 3-(4-Chlorophenyl)acrylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1615-02-7 SDS

1615-02-7Synthetic route

malonic acid
141-82-2

malonic acid

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With piperidine; pyridine at 22℃; for 3h; ultrasound;99%
With piperidine In pyridine for 5h; Reflux;99%
With aluminum oxide; lithium chloride for 0.1h; Doebner condensation; microwave irradiation;97%
methyl 3-(4-chlorophenyl)propenoate
20754-21-6

methyl 3-(4-chlorophenyl)propenoate

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With lithium hydroxide monohydrate In tetrahydrofuran; water at 20℃; for 2h;98%
(2RS,3SR)-2,3-dibromo-3-(4-chlorophenyl)propanoic acid
24653-99-4, 31357-32-1

(2RS,3SR)-2,3-dibromo-3-(4-chlorophenyl)propanoic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With zinc In acetic acid for 0.0166667h; microwave irradiation;97%
acrylic acid
79-10-7

acrylic acid

4-(chloro)benzenediazonium benzo[d][1,3,2]dithiazol-2-ide-1,1,3,3-tetraoxide

4-(chloro)benzenediazonium benzo[d][1,3,2]dithiazol-2-ide-1,1,3,3-tetraoxide

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With calcium carbonate; palladium diacetate In tetrahydrofuran at 60℃; for 4.5h; Heck arylation;96%
1-Chloro-4-iodobenzene
637-87-6

1-Chloro-4-iodobenzene

acrylic acid
79-10-7

acrylic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With potassium hydroxide; PS-PEG-NH-C(O)C6H4PPh2-PdCl(η3-C3H5) at 25℃; Heck reaction;95%
With tributyl-amine; silica-supported bidentate arsine palladium(0) In para-xylene at 100℃; for 6h; Heck arylation;95%
With tributyl-amine; Si-SH-Pd(0) In xylene at 100℃; for 6h;94%
carbon tetrabromide
558-13-4

carbon tetrabromide

1-nitro-2-(4-chlorophenyl)ethylene
101671-01-6

1-nitro-2-(4-chlorophenyl)ethylene

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With tris(2,2'-bipyridyl)ruthenium dichloride; water; diisopropylamine In acetonitrile at 20℃; for 10h; Inert atmosphere; Irradiation; stereoselective reaction;94%
bromochlorobenzene
106-39-8

bromochlorobenzene

acrylic acid
79-10-7

acrylic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In 1-methyl-pyrrolidin-2-one at 140℃; for 0.416667h; Heck Reaction;91%
With tributyl-amine; silica-supported bidentate arsine palladium(0); triphenylphosphine In para-xylene at 140℃; for 12h; Heck arylation;55%
malonic acid
141-82-2

malonic acid

sodium (4-chlorophenyl)(hydroxy)methanesulfonate
46175-04-6

sodium (4-chlorophenyl)(hydroxy)methanesulfonate

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With piperazine In ethylene glycol for 0.108333h; Knoevenagel condensation; microwave irradiation;90%
formic acid
64-18-6

formic acid

2-iodo-1-(4-chlorophenyl)ethylene

2-iodo-1-(4-chlorophenyl)ethylene

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With palladium diacetate; triethylamine; dicyclohexyl-carbodiimide; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In N,N-dimethyl-formamide at 100℃; for 20h; Inert atmosphere; Sealed tube;89%
4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

acetic acid
64-19-7

acetic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With pyridine; dmap; sodium tetraborate decahydrate; N-benzyl-N,N,N-triethylammonium chloride In 1-methyl-pyrrolidin-2-one at 185 - 190℃; for 8h;86%
With pyridine; dmap; lithium chloride In 1-methyl-pyrrolidin-2-one at 185 - 190℃; for 10h;83%
maleic anhydride
108-31-6

maleic anhydride

1-Chloro-4-iodobenzene
637-87-6

1-Chloro-4-iodobenzene

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With potassium carbonate In 1,4-dioxane at 125℃; chemoselective reaction;85%
ethyl (E)-3-(4-chlorophenyl)prop-2-enoate
24393-52-0

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With lithium hydroxide In tetrahydrofuran; water at 25℃; for 24h;81%
With potassium hydroxide In ethanol at 20℃; for 2h;
With water; lithium hydroxide In methanol at 20℃; for 16h;
With sodium hydroxide In ethanol; water at 60℃;
With lithium hydroxide In tetrahydrofuran; ethanol; water at 20℃; for 4h;
carbon dioxide
124-38-9

carbon dioxide

(E)-4-chlorostyrylboronic acid
154230-29-2

(E)-4-chlorostyrylboronic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With potassium methanolate; copper(l) chloride In N,N-dimethyl acetamide at 70℃; under 760.051 Torr; for 24h; Inert atmosphere; Schlenk technique; Sealed tube;80%
(E)-3-(p-chlorophenyl)prop-2-en-1-ol
24583-70-8

(E)-3-(p-chlorophenyl)prop-2-en-1-ol

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With potassium phosphate; carbon dioxide; CrH6Mo6O24(3-)*3H3N*3H(1+) In dimethyl sulfoxide at 80℃; under 750.075 Torr; for 24h; Green chemistry;80%
(E)-3-(4-Chloro-phenyl)-acrylic acid 4-nitro-benzyl ester

(E)-3-(4-Chloro-phenyl)-acrylic acid 4-nitro-benzyl ester

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With zinc In tetrahydrofuran for 2h; Ambient temperature;77%
carbon monoxide
201230-82-2

carbon monoxide

1-(2-bromovinyl)-4-chlorobenzene
66482-29-9, 66482-30-2, 125428-11-7

1-(2-bromovinyl)-4-chlorobenzene

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With [bmim]PF6; triethylamine; bis-triphenylphosphine-palladium(II) chloride In water at 100℃; under 15001.2 Torr; for 20h;76%
maleic anhydride
108-31-6

maleic anhydride

bromochlorobenzene
106-39-8

bromochlorobenzene

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With potassium carbonate In 1,4-dioxane at 130℃; chemoselective reaction;74%
(trimethylsilyl)ketene bis(trimethylsilyl) acetal
65946-59-0

(trimethylsilyl)ketene bis(trimethylsilyl) acetal

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With sodium fluoride In N,N-dimethyl-formamide for 5.5h;73%
3-(4-chlorophenyl)propanoic acid
2019-34-3

3-(4-chlorophenyl)propanoic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
Stage #1: 3-(4-chlorophenyl)propanoic acid With Zn(2,2,6,6-tetramethylpiperidine)2*2LiCl In tetrahydrofuran at -40℃; for 1.5h; Inert atmosphere; Sealed tube;
Stage #2: With bis(η3-allyl-μ-chloropalladium(II)); Allyl acetate In tetrahydrofuran at -40 - 60℃; for 3h; Inert atmosphere; Sealed tube; diastereoselective reaction;
66%
malonic acid
141-82-2

malonic acid

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

A

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

B

3-amino-3-(4-chlorophenyl)propionic acid hydrochloride

3-amino-3-(4-chlorophenyl)propionic acid hydrochloride

Conditions
ConditionsYield
Stage #1: malonic acid; 4-chlorobenzaldehyde With ammonium acetate In ethanol for 7h; Heating;
Stage #2: With hydrogenchloride
A n/a
B 65%
4-vinylbenzyl chloride
1073-67-2

4-vinylbenzyl chloride

carbon tetrabromide
558-13-4

carbon tetrabromide

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With Eosin Y; dimethyl sulfoxide; cobalt(II) iodide at 50℃; for 15h; Inert atmosphere; UV-irradiation;60%
(3E)-4-(4-chlorophenyl)-3-buten-2-one
30626-03-0

(3E)-4-(4-chlorophenyl)-3-buten-2-one

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With copper(l) iodide; hydroxylamine hydrochloride; oxygen In dimethyl sulfoxide at 100℃; for 12h;51%
ethyl acetoacetate
141-97-9

ethyl acetoacetate

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
Stage #1: 4-chlorobenzaldehyde With hydrogenchloride; sodium azide; sodium nitrite In water at 0 - 20℃; for 2h;
Stage #2: ethyl acetoacetate With triethylamine In N,N-dimethyl-formamide at 20℃;
Stage #3: With palladium on activated charcoal; hydrogen In ethyl acetate at 20℃; for 2h;
51%
diethylphosphonoacetic acid
3095-95-2

diethylphosphonoacetic acid

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

A

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

B

(E)-diethyl (4-chlorostyryl)phosphonate
125951-04-4

(E)-diethyl (4-chlorostyryl)phosphonate

Conditions
ConditionsYield
With piperidine; pyridine for 3h; Heating;A 21%
B 48%
p-chlorobenzylidenepropane-1,3-dioic acid
17449-02-4

p-chlorobenzylidenepropane-1,3-dioic acid

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

acetic anhydride
108-24-7

acetic anhydride

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With potassium acetate at 150 - 190℃;
With sodium acetate at 180 - 200℃;
4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With sodium acetate; acetic anhydride
Multi-step reaction with 2 steps
1: sodium hydride / tetrahydrofuran / 2 h / 0 - 20 °C
2: water; lithium hydroxide / methanol / 16 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydride / tetrahydrofuran; mineral oil / 0 - 60 °C
2: sodium hydroxide / ethanol; water / 60 °C
View Scheme
4-chloro-aniline
106-47-8

4-chloro-aniline

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With hydrogenchloride Diazotization.Eintragen in ein Gemisch von Maleinsaeure (oder Acrylsaeure), Kupfer(II)-chlorid, Natriumacetat und Wasser;
(E)-5-(4-chlorostyryl)-3-methyl-4-nitroisoxazole
51978-97-3

(E)-5-(4-chlorostyryl)-3-methyl-4-nitroisoxazole

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

Conditions
ConditionsYield
With sodium hydroxide for 6h; Heating;67 % Turnov.
-α-<<3-(4-chlorophenyl)-1-oxo-2-propenyl>oxy>benzenepropanoic acid
61556-61-4

-α-<<3-(4-chlorophenyl)-1-oxo-2-propenyl>oxy>benzenepropanoic acid

A

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

B

L-3-phenyllactic acid
20312-36-1

L-3-phenyllactic acid

Conditions
ConditionsYield
carboxypeptidase A In water at 25℃; Rate constant; Equilibrium constant; pH 7.5, ionic strength 0.55;
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

cinnamoyl chloride
35086-79-4, 95602-71-4

cinnamoyl chloride

Conditions
ConditionsYield
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 0 - 20℃; Inert atmosphere;100%
With thionyl chloride In N,N-dimethyl-formamide for 4h; Reflux;100%
With thionyl chloride In dichloromethane; N,N-dimethyl-formamide Reflux; Inert atmosphere;100%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

C9H7(2)H2ClO2

C9H7(2)H2ClO2

Conditions
ConditionsYield
With aluminum oxide; rhodium(III) chloride; potassium deuteroformate for 0.05h; microwave irradiation;100%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

benzylamine
100-46-9

benzylamine

(E)-N-benzyl-3-(4-chlorophenyl)acrylamide

(E)-N-benzyl-3-(4-chlorophenyl)acrylamide

Conditions
ConditionsYield
With Bromotrichloromethane; 4-(diphenylphosphino)-benzyltrimethylammonium bromide; triethylamine In tetrahydrofuran; dichloromethane at 60℃; for 6h; Inert atmosphere;99%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

methyl 3-(4-chlorophenyl)propenoate
20754-21-6

methyl 3-(4-chlorophenyl)propenoate

Conditions
ConditionsYield
In methanol; diethyl ether at 20℃; for 0.25h; Inert atmosphere;98%
In diethyl ether
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

ibuprofen
15687-27-1

ibuprofen

dibutyltin chloride
683-18-1

dibutyltin chloride

(E,Z)-dibutyl((2-(4-isobutylphenyl)propanoyl)oxy)stannyl 3-(4-chlorophenyl)acrylate

(E,Z)-dibutyl((2-(4-isobutylphenyl)propanoyl)oxy)stannyl 3-(4-chlorophenyl)acrylate

Conditions
ConditionsYield
With triethylamine In toluene at 80 - 110℃; for 18h;98%
ethanol
64-17-5

ethanol

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate
24393-52-0

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate

Conditions
ConditionsYield
With toluene-4-sulfonic acid for 24h; Fischer esterification; Heating;97%
With sulfuric acid for 30h; Reflux;70%
With sulfuric acid for 5h; Heating;64%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

α,β-dibromo-p-chlorohydrocinnamic acid
31357-32-1, 24653-99-4

α,β-dibromo-p-chlorohydrocinnamic acid

Conditions
ConditionsYield
With bromine In acetic acid at 0 - 20℃; for 3.5h;97%
With bromine In tetrachloromethane94%
With bromine In various solvent(s) at 95℃; for 2h;77%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

1-nitro-2-(4-chlorophenyl)ethylene
101671-01-6

1-nitro-2-(4-chlorophenyl)ethylene

Conditions
ConditionsYield
With chloro-trimethyl-silane; copper(II) nitrate trihydrate In acetonitrile at 100℃; for 2h; stereoselective reaction;97%
With ferric nitrate for 1h; Milling;86%
With quinoline; dipotassium peroxodisulfate; tert.-butylnitrite In acetonitrile at 85℃; for 5h;85%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate
24393-52-0

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate

Conditions
ConditionsYield
With sulfuric acid In ethanol; benzene97%
oxone

oxone

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

trans-β-(p-Chlorophenyl)glycidic acid
56010-48-1, 114380-31-3

trans-β-(p-Chlorophenyl)glycidic acid

Conditions
ConditionsYield
With hydrogenchloride; sodium hydrogencarbonate In water; ethyl acetate; acetone97%
methanol
67-56-1

methanol

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

methyl 3-(4-chlorophenyl)propenoate
20754-21-6

methyl 3-(4-chlorophenyl)propenoate

Conditions
ConditionsYield
With toluene-4-sulfonic acid Reflux;96%
Dowex H+ resin Heating;95%
With Dowex-WX4 In various solvent(s) Heating;95%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

o-phenylenediamine sulphate
74710-09-1

o-phenylenediamine sulphate

(E)-2-(4-chlorostyryl)-1H-benzo[d]imidazole
206982-69-6

(E)-2-(4-chlorostyryl)-1H-benzo[d]imidazole

Conditions
ConditionsYield
In ethylene glycol for 3h; Heating;96%
NH-pyrazole
288-13-1

NH-pyrazole

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

(E)-3-(4-chlorophenyl)-1-(1H-pyrazol-1-yl)prop-2-en-1-one

(E)-3-(4-chlorophenyl)-1-(1H-pyrazol-1-yl)prop-2-en-1-one

Conditions
ConditionsYield
Stage #1: NH-pyrazole With thionyl chloride In dichloromethane at 0 - 25℃; for 1h;
Stage #2: 3-(4-chlorophenyl)prop-2-enoic acid In dichloromethane for 3h;
96%
Stage #1: NH-pyrazole With thionyl chloride In dichloromethane at 0 - 20℃; for 1h;
Stage #2: 3-(4-chlorophenyl)prop-2-enoic acid In dichloromethane for 3h;
96%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

(E)-3-(4-chlorophenyl)-N-methoxy-N-methylacrylamide
771557-40-5

(E)-3-(4-chlorophenyl)-N-methoxy-N-methylacrylamide

Conditions
ConditionsYield
With sodium hydrogencarbonate; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;96%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

methyl 3-(4-chlorophenyl)propenoate
20754-21-6

methyl 3-(4-chlorophenyl)propenoate

Conditions
ConditionsYield
With sulfuric acid In methanol95%
With hydrogenchloride; methanol
Multi-step reaction with 2 steps
1: SOCl2
2: methanol
View Scheme
With sulfuric acid In methanol
Multi-step reaction with 2 steps
1: thionyl chloride / 1 h / 20 °C
2: dichloromethane / 0.5 h / 20 °C
View Scheme
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

(2RS,3SR)-2,3-dibromo-3-(4-chlorophenyl)propanoic acid
24653-99-4, 31357-32-1

(2RS,3SR)-2,3-dibromo-3-(4-chlorophenyl)propanoic acid

Conditions
ConditionsYield
With copper(II) nitrate trihydrate; trimethylsilyl bromide In acetonitrile at 50℃; for 2h;95%
With selenium(IV) oxide; hydrogen bromide In diethyl ether Ambient temperature;35%
With chloroform; bromine at 20℃;
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

(E)-3-(4-Chloro-phenyl)-acryloyl azide
83421-78-7

(E)-3-(4-Chloro-phenyl)-acryloyl azide

Conditions
ConditionsYield
With sodium azide; N,N-dimethyl-formamide; trichlorophosphate at 10 - 15℃; for 3h;95%
With diphenyl phosphoryl azide; triethylamine In toluene at 20℃; Inert atmosphere;80%
With thionyl chloride; sodium azide 1) 1 h, reflux, 2) 1 h, acetone, water; Yield given. Multistep reaction;
Multi-step reaction with 2 steps
1: triethylamine / acetone / 1 h / 0 °C
2: sodium azide / acetone; H2O / 16 h / 20 °C
View Scheme
With diphenyl phosphoryl azide; triethylamine In toluene at 20℃; for 3h; Cooling with ice;
(3S,5S)-3-(2-tert-butoxycarbonylaminoethyl)-5-(aminomethyl)-1-(2-ethylbutyl)-1,4-diazepan-2-one
1185654-13-0

(3S,5S)-3-(2-tert-butoxycarbonylaminoethyl)-5-(aminomethyl)-1-(2-ethylbutyl)-1,4-diazepan-2-one

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

(E)-N-(((3S,5S)-3-(2-aminoethyl)-1-(2-ethylbutyl)-2-oxo-1,4-diazepan-5-yl)methyl)-3-(4-chlorophenyl)acrylamide
1185652-50-9

(E)-N-(((3S,5S)-3-(2-aminoethyl)-1-(2-ethylbutyl)-2-oxo-1,4-diazepan-5-yl)methyl)-3-(4-chlorophenyl)acrylamide

Conditions
ConditionsYield
Stage #1: (3S,5S)-3-(2-tert-butoxycarbonylaminoethyl)-5-(aminomethyl)-1-(2-ethylbutyl)-1,4-diazepan-2-one; 3-(4-chlorophenyl)prop-2-enoic acid With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h;
Stage #2: With trifluoroacetic acid In dichloromethane at 20℃; for 1h;
95%
Stage #1: (3S,5S)-3-(2-tert-butoxycarbonylaminoethyl)-5-(aminomethyl)-1-(2-ethylbutyl)-1,4-diazepan-2-one; 3-(4-chlorophenyl)prop-2-enoic acid With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h;
Stage #2: With trifluoroacetic acid In dichloromethane at 20℃; for 1h;
95%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

methoxybenzene
100-66-3

methoxybenzene

4'-methoxy-4-chlorochalcone
6552-68-7, 30925-57-6, 41564-68-5

4'-methoxy-4-chlorochalcone

Conditions
ConditionsYield
With phosphoric acid; trifluoroacetic acid at 20℃; for 3h;95%
p-cresol
106-44-5

p-cresol

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

4-(4-chlorophenyl)-6-methylchroman-2-one

4-(4-chlorophenyl)-6-methylchroman-2-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid at 125℃; for 3h;94%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

N-isocyaniminotriphenylphosphorane
73789-56-7

N-isocyaniminotriphenylphosphorane

dimethylglyoxal
431-03-8

dimethylglyoxal

3-{5-[(E)-2-(4-chlorophenyl)-1-ethenyl]-1,3,4-oxadiazol-2-yl}-3-hydroxy-2-butanone
1443438-81-0

3-{5-[(E)-2-(4-chlorophenyl)-1-ethenyl]-1,3,4-oxadiazol-2-yl}-3-hydroxy-2-butanone

Conditions
ConditionsYield
In dichloromethane at 20℃; for 0.333333h; Aza-Wittig Reaction; Sonication;94%
In water at 20 - 26℃; for 12h; Green chemistry;90%
In dichloromethane at 20℃; for 12h; Aza-Wittig Reaction; Neutral conditions;88%
cyclohexyl-N-tosyl aziridine
68820-12-2

cyclohexyl-N-tosyl aziridine

3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

2-((4-Methylphenyl)sulfonamido)cyclohexyl (E)-3-(4-chlorophenyl)acrylate

2-((4-Methylphenyl)sulfonamido)cyclohexyl (E)-3-(4-chlorophenyl)acrylate

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 50℃; Green chemistry;94%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

propargyl bromide
106-96-7

propargyl bromide

prop-2-yn-1-yl (E)-3-(4-chlorophenyl)acrylate

prop-2-yn-1-yl (E)-3-(4-chlorophenyl)acrylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; toluene at 20℃; for 48h; Inert atmosphere;94%
3-(4-chlorophenyl)prop-2-enoic acid
1615-02-7

3-(4-chlorophenyl)prop-2-enoic acid

(R)-4-(phenylmethyl)-2-oxazolidinone
40217-17-2, 90719-32-7, 120574-96-1, 102029-44-7

(R)-4-(phenylmethyl)-2-oxazolidinone

(4R)-4-benzyl-3-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-1,3-oxazolidin-2-one
1000415-73-5

(4R)-4-benzyl-3-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-1,3-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 3-(4-chlorophenyl)prop-2-enoic acid; (R)-4-(phenylmethyl)-2-oxazolidinone With pivaloyl chloride; triethylamine In tetrahydrofuran at -20℃; for 2h;
Stage #2: With lithium chloride In tetrahydrofuran at -20℃; for 16h; Further stages.;
93%

1615-02-7Relevant articles and documents

Structural elucidation and bioassays of newly synthesized pentavalent antimony complexes

Iftikhar, Tuba,Rauf, Muhammad Khawar,Sarwar, Sidra,Badshah, Amin,Waseem, Durdana,Tahir, Muhammad Nawaz,Khan, Amjad,Khan, Khalid Mohammad,Khan, Gul Majid

, p. 89 - 96 (2017)

Antimony (V) organometallics (1–5) have been synthesized with general formula [SbR′3(O2CR)2], where R' = phenyl, p-tolyl and O2CR are substituted cinnamates. These complexes have been characterized by FT-IR analysis, multinuclear (1H, 13C) NMR spectroscopy and single crystal X-ray diffraction analysis. The crystal structures of [Sb(phenyl)3(4-ClC6H4C2H2O2C)2] (1) and [Sb(p-tol)3(4-OCH3C6H4C2H2O2C)2].CHCl3 (5) displayed distorted geometry between trigonal bipyramidal and square pyramidal with monomeric structure at a five coordinated Sb center. Starting reagents and complexes were evaluated for anticancer, antileishmanial, antibacterial and alpha amylase inhibition potentials. It was observed that complexes 3, 4 and 5 showed significant (p 0.05) antileishmanial and anticancer activities against Leishmania tropica KWH23 promastigotes and HepG2 cell lines respectively. Antibacterial activity of compound 3 was also significant against E. coli (MIC: 5.55 μg/mL), K. pneumoniae (MIC: 16.66 μg/mL), S. aureus (MIC: 5.55 μg/mL) and P. aeruginosa (MIC: 50 μg/mL). Hence, these new antimony complexes can act as good drug candidates.

Larvicidal activity and in silico studies of cinnamic acid derivatives against Aedes aegypti (Diptera: Culicidae)

Bezerra Fran?a, Saraliny,Carine Barros de Lima, Luana,Rychard da Silva Cunha, Cristhyan,Santos Anuncia??o, Daniela,Ferreira da Silva-Júnior, Edeildo,Ester de Sá Barreto Barros, Maria,José da Paz Lima, Dimas

, (2021/07/07)

Cinnamic acid derivatives (CAD's) represent a great alternative in the search for insecticides against Aedes aegypti mosquitoes since they have antimicrobial and insecticide properties. Ae. aegypti is responsible for transmitting Dengue, Chikungunya, and Zika viruses, among other arboviruses associated with morbimortality, especially in developing countries. In view of this, in vitro analyses of n-substituted cinnamic acids and esters were performed upon 4th instar larvae (L4) of Ae. aegypti, as well as, molecular docking studies to propose a potential biological target towards this mosquitoes species. The larvicide assays proved that n-substituted ethyl cinnamates showed a more pronounced activity than their corresponding acids, in which p-chlorocinnamate (3j) presented a LC50 value of 8.3 μg/mL. Thusly, external morphologic alterations (rigid and elongated body, curved bowel, and translucent or darkened anal papillae) of mosquitoes’ group exposed to compound 3j, were observed by microscopy. In addition, an analytical method was developed for the quantification of the most promising analog by using high-performance liquid chromatography with UV detection (HPLC-UV). Molecular docking studies suggested that the larvicide action is associated with inhibition of acetylcholinesterase (AChE) enzyme. Therefore, expanding the larvicidal study with the cinnamic acid derivatives against the vector Ae. aegypti is important for finding search for more effective larvicides and with lower toxicity, since they have already shown good larvicidal properties against Ae. aegypti.

Photocatalytic Oxidative [2+2] Cycloelimination Reactions with Flavinium Salts: Mechanistic Study and Influence of the Catalyst Structure

Hartman, Tomá?,Reisnerová, Martina,Chudoba, Josef,Svobodová, Eva,Archipowa, Nataliya,Kutta, Roger Jan,Cibulka, Radek

, p. 373 - 386 (2021/02/01)

Flavinium salts are frequently used in organocatalysis but their application in photoredox catalysis has not been systematically investigated to date. We synthesized a series of 5-ethyl-1,3-dimethylalloxazinium salts with different substituents in the positions 7 and 8 and investigated their application in light-dependent oxidative cycloelimination of cyclobutanes. Detailed mechanistic investigations with a coumarin dimer as a model substrate reveal that the reaction preferentially occurs via the triplet-born radical pair after electron transfer from the substrate to the triplet state of an alloxazinium salt. The very photostable 7,8-dimethoxy derivative is a superior catalyst with a sufficiently high oxidation power (E=2.26 V) allowing the conversion of various cyclobutanes (with Eox up to 2.05 V) in high yields. Even compounds such as all-trans dimethyl 3,4-bis(4-methoxyphenyl)cyclobutane-1,2-dicarboxylate can be converted, whose opening requires a high activation energy due to a missing pre-activation caused by bulky adjacent substituents in cis-position.

Discovery of 3-cinnamamido-n-substituted benzamides as potential antimalarial agents

Futamura, Yushi,Ishiyama, Aki,Iwatsuki, Masato,Liu, Haicheng,Osada, Hiroyuki,Shi, Tao,Wu, Honghai,Zhang, Taotao,Zheng, Qunxiong,Zou, Hongbin,ōmura, Satoshi

, p. 1207 - 1218 (2022/01/06)

Background: Malaria is one of the most devastating parasitic diseases, yet the discovery of antimalarial agents remains profoundly challenging. Very few new antimalarials have been developed in the past 50 years, while the emergence of drug-resistance continues to appear. Objective: This study focuses on the discovery, design, synthesis, and antimalarial evaluation of 3- cinnamamido-N-substituted benzamides. Methods: In this study, a screening of our compound library was carried out against the multidrugsensitive Plasmodium falciparum 3D7 strain. Derivatives of the hit were designed, synthesized and tested against P. falciparum 3D7 and the in vivo antimalarial activity of the most active compounds was evaluated using the method of Peters’ 4-day suppressive test. Results: The retrieved hit compound 1 containing a 3-cinnamamido-N-substituted benzamide skeleton showed moderate antimalarial activity (IC50 = 1.20 μM) for the first time. A series of derivatives were then synthesized through a simple four-step workflow, and half of them exhibited slightly better antimalarial effect than the precursor 1 during the subsequent in vitro assays. Additionally, compounds 11, 23, 30 and 31 displayed potent activity with IC50 values of approximately 0.1 μM, and weak cytotoxicity against mammalian cells. However, in vivo antimalarial activity is not effective, which might be ascribed to the poor solubility of these compounds. Conclusion: In this study, the phenotypic screen of our compound library resulted in the first report of a 3-cinnamamide framework with antimalarial activity and 40 derivatives were then designed and synthesized. Subsequent structure-activity studies showed that compounds 11, 23, 30 and 31 exhibited the most potent and selective activity against the P. falciparum 3D7 strain with IC50 values around 0.1 μM. Our work herein sets another example of phenotypic screen-based drug discovery, leading to potentially promising candidates of novel antimalarial agents once given further optimization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1615-02-7